Am J Perinatol 2024; 41(07): 859-866
DOI: 10.1055/s-0042-1748156
Original Article

Cervical Length Ultrasound for the Evaluation of Preterm Labor: A Survey of National Use and Review of Evidence

1   Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
,
2   Division of Maternal-Fetal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
,
Helen Feltovich
3   Women's Department, Maternal-Fetal Medicine Division, Intermountain Healthcare, Salt Lake City Utah
,
Michael House
4   Division of Maternal-Fetal Medicine, Tufts Medical Center, Boston, Massachusetts
› Author Affiliations
Funding R.C.B. was supported by a PhRMA Foundation Faculty Development Award.

Abstract

Objective The objective of this study was to survey national utilization of cervical length (CL) ultrasound on labor and delivery (L&D) for the evaluation of preterm labor (PTL) and identify provider attitudes and barriers to utilization.

Study Design Survey was emailed to Obstetrics and Gynecology Residency and Maternal-Fetal Medicine Fellowship program and advertised via links on obstetric-related Facebook interest groups. The survey was open from August 4, 2020 to January 4, 2021. Characteristics between respondents who did and did not report the use of CL ultrasound for PTL evaluation were compared with chi-square analysis.

Results There were 214 respondents across 42 states. One hundred and thirty-four respondents (63%) reported any use of CL in the evaluation of PTL and eighty (37%) denied it. There was a significant difference in practice location, practice type, delivery volume, and region between those who did and did not utilize CL ultrasound on L&D. Those who did use CL ultrasound were more likely to report no barriers to use (40 vs. 4%, p < 0.001). The most common barriers involved the availability of transvaginal ultrasound (31%), sterilization of transvaginal ultrasound probe (32%), limited availability of persons able to perform/interpret CL imaging (38%). Nineteen percent believed CL ultrasound had little/no utility in clinical practice. Those who did not use CL ultrasound in the evaluation of PTL were significantly more likely to report the feeling that there was little/no utility of CL ultrasound in clinical practice (37 vs. 7%, p < 0.001) and to report transvaginal ultrasound availability as barriers to use (63 vs. 12%, p < 0.001).

Conclusion CL ultrasound is used nationally in PTL evaluation. However, significant barriers limit widespread adoption. These barriers can be addressed through the dissemination of information and practice guidelines, addition of CL ultrasound education in residency training and through CME opportunities after training, and providing support/resources/access for those looking to add this tool to their practice environment.

Key Points

  • In a national survey, 63% of obstetricians endorsed any use of cervical length (CL) ultrasound for preterm labor evaluation on labor and delivery.

  • The most common barriers involved the availability of transvaginal ultrasound (31%), sterilization of transvaginal ultrasound probe (32%), limited availability of persons able to perform/interpret CL imaging (38%).

  • Those who did not use CL ultrasound in the evaluation of PTL were significantly more likely to report the feeling that there was little/no utility of CL ultrasound in clinical practice and to report transvaginal ultrasound availability as barriers to utilization.

  • Barriers to utilization of CL ultrasound for preterm labor evaluation can be addressed through practice guidelines, ultrasound education, and support for equipment/training necessary for use.

Note

This publication was supported by the Perinatal Quality Foundation, a non-profit organization that provides the certification of cervical length imaging in pregnancy (clear.perinatalquality.org). The authors are volunteers for the Perinatal Quality Foundation.


Supplementary Material



Publication History

Received: 04 May 2021

Accepted: 18 February 2022

Article published online:
17 May 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 McIntosh J, Feltovich H, Berghella V, Manuck T. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol 2016; 215 (03) B2-B7
  • 2 Temming LA, Durst JK, Tuuli MG. et al. Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol 2016; 214 (04) 523.e1-523.e8
  • 3 Son M, Grobman WA, Ayala NK, Miller ES. A universal mid-trimester transvaginal cervical length screening program and its associated reduced preterm birth rate. Am J Obstet Gynecol 2016; 214 (03) 365.e1-365.e5
  • 4 Werner EF, Hamel MS, Orzechowski K, Berghella V, Thung SF. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. Am J Obstet Gynecol 2015; 213 (04) 554.e1-554.e6
  • 5 Cahill AG, Odibo AO, Caughey AB. et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010; 202 (06) 548.e1-548.e8
  • 6 Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120 (04) 964-973
  • 7 Chiossi G, Saade GR, Sibai B, Berghella V. Using cervical length measurement for lower spontaneous preterm birth rates among women with threatened preterm labor. Obstet Gynecol 2018; 132 (01) 102-106
  • 8 Berghella V, Palacio M, Ness A, Alfirevic Z, Nicolaides KH, Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol 2017; 49 (03) 322-329
  • 9 Ness A, Visintine J, Ricci E, Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol 2007; 197 (04) 426.e1-426.e7
  • 10 Lucovnik M, Chambliss LR, Garfield RE. Costs of unnecessary admissions and treatments for “threatened preterm labor”. Am J Obstet Gynecol 2013; 209 (03) 217.e1-217.e3
  • 11 ACOG. Practice Bulletin 171: management of preterm labor. Obstet Gynecol 2016; 128: 155-164
  • 12 Melamed N, Asztalos E, Murphy K. et al. Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study. BMJ Open 2019; 9 (09) e031197
  • 13 Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA 2020; 323 (19) 1924-1933
  • 14 DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013; 208 (03) 233.e1-233.e6
  • 15 Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Am J Obstet Gynecol 2014; 210 (01) 54.e1-54.e10
  • 16 Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol 2010; 35 (01) 54-64
  • 17 Bruijn M, Vis JY, Wilms FF. et al. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women. BJOG 2016; 123 (12) 1965-1971
  • 18 Hiersch L, Melamed N, Aviram A, Bardin R, Yogev Y, Ashwal E. Role of cervical length measurement for preterm delivery prediction in women with threatened preterm labor and cervical dilatation. J Ultrasound Med 2016; 35 (12) 2631-2640
  • 19 Berghella V, Saccone G. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev 2019; 9 (09) CD007235
  • 20 Alfirevic Z, Allen-Coward H, Molina F, Vinuesa CP, Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol 2007; 29 (01) 47-50
  • 21 Palacio M, Caradeux J, Sánchez M. et al. Uterine cervical length measurement to reduce length of stay in patients admitted for threatened preterm labor: a randomized trial. Fetal Diagn Ther 2018; 43 (03) 184-190
  • 22 van Baaren GJ, Vis JY, Wilms FF. et al. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor. Ultrasound Obstet Gynecol 2018; 51 (05) 596-603
  • 23 Society for Maternal-Fetal Medicine (SMFM) Publications Committee. SMFM Preterm Birth Tookit. Accessed February 15, 2022 at: https://www.smfm.org/publications/231-smfm-preterm-birth-toolkit
  • 24 Boelig RC, Feltovich H, Spitz JL, Toland G, Berghella V, Iams JD. Perinatal Quality Foundation. Assessment of transvaginal ultrasound cervical length image quality. Obstet Gynecol 2017; 129 (03) 536-541
  • 25 Khalifeh A, Quist-Nelson J, Berghella V. Universal cervical length screening for preterm birth prevention in the United States. J Matern Fetal Neonatal Med 2017; 30 (12) 1500-1503
  • 26 Martell B, DiBenedetti DB, Weiss H. et al. Screening and treatment for short cervical length in pregnancy: a physician survey in the United States. Arch Gynecol Obstet 2018; 297 (03) 601-611